Primary mediastinal large B-cell lymphoma other diagnostic studies

Revision as of 03:11, 3 January 2019 by Badria Munir (talk | contribs) (Created page with "__NOTOC__ {{Primary mediastinal large B-cell lymphoma other diagnostic studies}} {{CMG}}; {{AE}} {{Badria}} ==Overview== Monoclonal anti-MAL antibody is now commercially used...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Primary mediastinal large B-cell lymphoma other diagnostic studies Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2]

Overview

Monoclonal anti-MAL antibody is now commercially used in order to identify primary mediastinal large B-cell lymphoma

Other Diagnostic Studies

  • Monoclonal anti-MAL antibody is now commercially used in order to identify primary mediastinal large B-cell lymphoma. It provides good sensitivity and high specificity for diagnosis of primary mediastinal large B-cell lymphoma. [1]

References

  1. ↑ Traverse-Glehen A, Pittaluga S, Gaulard P, Sorbara L, Alonso MA, Raffeld M, Jaffe ES (November 2005). "Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma". Am. J. Surg. Pathol. 29 (11): 1411–21. PMID 16224207.
Retrieved from "https://www.wikidoc.org/index.php?title=Primary_mediastinal_large_B-cell_lymphoma_other_diagnostic_studies&oldid=1513840"